Literature DB >> 10531326

A novel human apolipoprotein (apoM).

N Xu1, B Dahlbäck.   

Abstract

A novel human apolipoprotein designated apolipoprotein M (apoM) is described. The unique N-terminal amino acid sequence of apoM was found in an approximately 26-kDa protein present in a protein extract of triglyceride-rich lipoproteins (TGRLP). The isolated apoM cDNA (734 base pairs) encoded a 188-amino acid residue-long protein, distantly related to the lipocalin family. The mRNA of apoM was detected in the liver and kidney. Western blotting demonstrated apoM to be present in high density lipoprotein (HDL) and to a lesser extent in TGRLP and low density lipoproteins (LDL). The first 20 amino acid residues of apoM constituted a hydrophobic segment with characteristic features of a signal peptide. This was retained in the mature protein because of the lack of a signal peptidase cleavage site. In vitro translation in the presence of microsomes demonstrated translocation of apoM over the membrane and glycosylation but no signal peptide cleavage. The in vitro translated product remained associated with the microsomes after treatment with carbonate at pH 11, demonstrating that apoM is an integral protein. This finding suggests that apoM is linked to the single phospholipid layer of lipoproteins with a hydrophobic signal anchor. In conclusion, a novel human apolipoprotein, the function of which remains to be determined, is described.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531326     DOI: 10.1074/jbc.274.44.31286

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  110 in total

1.  Plasma apoM and S1P levels are inversely associated with mortality in African Americans with type 2 diabetes mellitus.

Authors:  Mingxia Liu; Cecilia Frej; Carl D Langefeld; Jasmin Divers; Donald W Bowden; J Jeffrey Carr; Abraham K Gebre; Jianzhao Xu; Benny Larsson; Björn Dahlbäck; Barry I Freedman; John S Parks
Journal:  J Lipid Res       Date:  2019-05-27       Impact factor: 5.922

2.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

Authors:  Tomas Vaisar; Subramaniam Pennathur; Pattie S Green; Sina A Gharib; Andrew N Hoofnagle; Marian C Cheung; Jaeman Byun; Simona Vuletic; Sean Kassim; Pragya Singh; Helen Chea; Robert H Knopp; John Brunzell; Randolph Geary; Alan Chait; Xue-Qiao Zhao; Keith Elkon; Santica Marcovina; Paul Ridker; John F Oram; Jay W Heinecke
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

3.  Association of apolipoprotein M gene polymorphisms with ischemic stroke in a Han Chinese population.

Authors:  Dongxue Zhao; Zhiyi He; Xue Qin; Lei Li; Fang Liu; Shumin Deng
Journal:  J Mol Neurosci       Date:  2010-09-25       Impact factor: 3.444

4.  Common variants at the promoter region of the APOM confer a risk of rheumatoid arthritis.

Authors:  Hae Jin Hu; Eun Heui Jin; Seon Hee Yim; So Young Yang; Seung Hyun Jung; Seung Hun Shin; Wan Uk Kim; Seung Cheol Shim; Tai Gyu Kim; Yeun Jun Chung
Journal:  Exp Mol Med       Date:  2011-11-30       Impact factor: 8.718

5.  Editorial on Sramkova et al., "Apolipoprotein M: a novel adipokine decreasing with obesity and upregulated by calorie restriction".

Authors:  Chih-Wei Ko; Jie Qu; Patrick Tso
Journal:  Am J Clin Nutr       Date:  2019-06-01       Impact factor: 7.045

6.  Peptide serum markers in islet autoantibody-positive children.

Authors:  Christine von Toerne; Michael Laimighofer; Peter Achenbach; Andreas Beyerlein; Tonia de Las Heras Gala; Jan Krumsiek; Fabian J Theis; Anette G Ziegler; Stefanie M Hauck
Journal:  Diabetologia       Date:  2016-11-04       Impact factor: 10.122

7.  Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data.

Authors:  C Brorsson; N T Hansen; K Lage; R Bergholdt; S Brunak; F Pociot
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

8.  Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.

Authors:  Toshihiro Sakurai; Akiko Sakurai; Boris L Vaisman; Marcelo J Amar; Chengyu Liu; Scott M Gordon; Steven K Drake; Milton Pryor; Maureen L Sampson; Ling Yang; Lita A Freeman; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2015-11-16       Impact factor: 4.030

9.  Determination of single-nucleotide polymorphism in the proximal promoter region of apolipoprotein M gene in coronary artery diseases.

Authors:  Lu Zheng; Guanghua Luo; Xiaoying Zhang; Jun Zhang; Jiang Zhu; Jiang Wei; Qinfeng Mu; Lujun Chen; Peter Nilsson-Ehle; Ning Xu
Journal:  Int J Gen Med       Date:  2009-12-29

10.  Expression and localization of apolipoprotein M in human colorectal tissues.

Authors:  Guanghua Luo; Xiaoying Zhang; Qinfeng Mu; Lujun Chen; Lu Zheng; Jiang Wei; Maria Berggren-Söderlund; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2010-09-16       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.